Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes
The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-04-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.52 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849220306114183168 |
|---|---|
| author | Jack Wei Chieh Tan David Sim Junya Ako Wael Almahmeed Mark E Cooper Jamshed J Dalal Chaicharn Deerochanawong David Wei Chun Huang Sofian Johar Upendra Kaul Sin Gon Kim Natalie Koh Alice Pik-Shan Kong Rungroj Krittayaphong Bernard Kwok Bien J Matawaran Quang Ngoc Nguyen Loke Meng Ong Jin Joo Park Yongde Peng David KL Quek Ketut Suastika Norlela Sukor Boon Wee Teo Chee Kiang Teoh Jian Zhang Eugenio B Reyes Su Yen Goh |
| author_facet | Jack Wei Chieh Tan David Sim Junya Ako Wael Almahmeed Mark E Cooper Jamshed J Dalal Chaicharn Deerochanawong David Wei Chun Huang Sofian Johar Upendra Kaul Sin Gon Kim Natalie Koh Alice Pik-Shan Kong Rungroj Krittayaphong Bernard Kwok Bien J Matawaran Quang Ngoc Nguyen Loke Meng Ong Jin Joo Park Yongde Peng David KL Quek Ketut Suastika Norlela Sukor Boon Wee Teo Chee Kiang Teoh Jian Zhang Eugenio B Reyes Su Yen Goh |
| author_sort | Jack Wei Chieh Tan |
| collection | DOAJ |
| description | The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease. |
| format | Article |
| id | doaj-art-130d3392c78e4cfd8984f9006ed84963 |
| institution | Kabale University |
| issn | 1758-3756 1758-3764 |
| language | English |
| publishDate | 2021-04-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | European Cardiology Review |
| spelling | doaj-art-130d3392c78e4cfd8984f9006ed849632024-12-14T16:02:39ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642021-04-011610.15420/ecr.2020.52Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 DiabetesJack Wei Chieh Tan0David Sim1Junya Ako2Wael Almahmeed3Mark E Cooper4Jamshed J Dalal5Chaicharn Deerochanawong6David Wei Chun Huang7Sofian Johar8Upendra Kaul9Sin Gon Kim10Natalie Koh11Alice Pik-Shan Kong12Rungroj Krittayaphong13Bernard Kwok14Bien J Matawaran15Quang Ngoc Nguyen16Loke Meng Ong17Jin Joo Park18Yongde Peng19David KL Quek20Ketut Suastika21Norlela Sukor22Boon Wee Teo23Chee Kiang Teoh24Jian Zhang25Eugenio B Reyes26Su Yen Goh27National Heart Centre, Singapore; Sengkang General Hospital, SingaporeSengkang General Hospital, SingaporeKitasato University and Hospital, Tokyo, JapanCleveland Clinic Abu Dhabi, United Arab EmiratesMonash University, Melbourne, AustraliaCardiac Sciences, Kokilaben Hospital, Mumbai, IndiaRajavithi Hospital, Rangsit Medical School, ThailandDepartment of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Physical Therapy, Fooyin University, Kaohsiung, TaiwanRipas Hospital, BruneiBatra Hospital and Medical Research Centre, New Delhi, IndiaKorea University College of Medicine, Seoul, South KoreaNational Heart Centre, SingaporeThe Chinese University of Hong Kong, Hong Kong, ChinaSiriraj Hospital, Mahidol University, Bangkok, ThailandFarrer Park Medical Centre, SingaporeUniversity of Santo Tomas, Manila, the PhilippinesDepartment of Cardiology, Vietnam National Heart Institute, Hanoi Medical University, Hanoi, VietnamPenang General Hospital, Penang, MalaysiaSeoul National University Bundang Hospital, Seongnam, South KoreaShanghai Jiatong University, Shanghai, ChinaPantai Hospital Kuala Lumpur, Kuala Lumpur, MalaysiaUdayana University, Bali, IndonesiaDepartment of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, MalaysiaYong Loo Ling School of Medicine, National University of Singapore, SingaporeInstitut Jantung Negara, Kuala Lumpur, MalaysiaPeking Union Medical College, Beijing, ChinaDivision of Cardiovascular Medicine, University of the Philippines, Philippine General Hospital, University of the Philippines Manila, Manila, the PhilippinesSingapore General Hospital, SingaporeThe Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.https://www.ecrjournal.com/articleindex/ecr.2020.52 |
| spellingShingle | Jack Wei Chieh Tan David Sim Junya Ako Wael Almahmeed Mark E Cooper Jamshed J Dalal Chaicharn Deerochanawong David Wei Chun Huang Sofian Johar Upendra Kaul Sin Gon Kim Natalie Koh Alice Pik-Shan Kong Rungroj Krittayaphong Bernard Kwok Bien J Matawaran Quang Ngoc Nguyen Loke Meng Ong Jin Joo Park Yongde Peng David KL Quek Ketut Suastika Norlela Sukor Boon Wee Teo Chee Kiang Teoh Jian Zhang Eugenio B Reyes Su Yen Goh Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes European Cardiology Review |
| title | Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_full | Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_fullStr | Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_full_unstemmed | Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_short | Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes |
| title_sort | consensus recommendations by the asian pacific society of cardiology optimising cardiovascular outcomes in patients with type 2 diabetes |
| url | https://www.ecrjournal.com/articleindex/ecr.2020.52 |
| work_keys_str_mv | AT jackweichiehtan consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT davidsim consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT junyaako consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT waelalmahmeed consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT markecooper consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT jamshedjdalal consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT chaicharndeerochanawong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT davidweichunhuang consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT sofianjohar consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT upendrakaul consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT singonkim consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT nataliekoh consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT alicepikshankong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT rungrojkrittayaphong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT bernardkwok consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT bienjmatawaran consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT quangngocnguyen consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT lokemengong consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT jinjoopark consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT yongdepeng consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT davidklquek consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT ketutsuastika consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT norlelasukor consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT boonweeteo consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT cheekiangteoh consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT jianzhang consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT eugeniobreyes consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes AT suyengoh consensusrecommendationsbytheasianpacificsocietyofcardiologyoptimisingcardiovascularoutcomesinpatientswithtype2diabetes |